Spectrum: Clinical Decision Support for Infectious Disease, for Prisma Health-Midlands
Home Home
guidelines Created with Sketch. Guidelines
pathogens Created with Sketch. Pathogens
Antimicrobials Antimicrobials

Fidaxomicin

Restricted
C difficile risk
None
Oral Bioavailability
None

Spectrum Of Activity

Spectrum Of Activity

Dosing

Adult

C. difficile 200mg po BID x 10days

General Information

Common Usage

C. difficile colitis

Adverse Effects

  • GI disturbance

  • Cytopenias

  • Hypersensitivity: facial, tongue or throat swelling

Additional Information

Consult Infectious Disease

Pharmacology

Antimicrobial class: Specialized anti-C. difficile macrocyclic agent

Pregnancy category: B

Urine penetration: None

Lung penetration: None

CSF penetration: None

Biliary penetration: None